HomeOpen Access NewsPharmaceutical Industry

Pharmaceutical Industry

UK Government and CPE agree on record funding deal to expand pharmacy services

Patients will benefit from new pharmacy services, as the Government and Community Pharmacy England (CPE) agree on a £617m investment.

How to compete with COVID-19 with a computer?

Y-h. Taguchi, Professor at Chuo University in Japan, reveals how to compete with COVID-19 by using a computer.

Pfizer COVID-19 pill 89% effective against death

Pfizer has announced that its antiviral pill, PAXLOVID, is 89% effective in reducing COVID-19 hospitalisation and death.

TIGRR: Is it a wonderful thing for the UK’s Cannabis Industry?

BCL Solicitors LLP ask if a new report should put a spring in the step of UK businesses with an interest in medicinal cannabis and cannabidiol (CBD).

The risks of anabolic steroids

Dr Deborah Lee, Dr Fox Online Pharmacy, explores the risks associated with anabolic steroids and how to get help if you have an addiction.

Are you eligible for the COVID-19 booster jab?

Find out everything you need to know about the UK Government's COVID-19 vaccination programme as the NHS begins to rollout booster jabs.

New EU rules on veterinary medicines to support responsible use of antibiotics

Roxane Feller, AnimalhealthEurope Secretary-General, tells us all about the new EU rules on veterinary medicines to support more responsible use of antibiotics.

Mirtazapine not effective in treating dementia patients

Mirtazapine, an antidepressant drug given to dementia patients, has been found to be no more effective than a placebo and increases mortality.

Risk of pregnancy loss not associated with COVID-19 vaccines

According to a new study, there is no risk of pregnancy loss associated with COVID-19 vaccinations.

FDA approves Pfizer booster vaccine for over 65s

The U.S. Food and Drug Administration (FDA) has given authorisation for the Pfizer/BioNTech COVID-19 booster vaccine to be administered to people aged 65 and over.

Changing the treatment paradigm in Inflammatory Bowel Diseases

Prof. Hartmut J. Ehrlich, M.D., CEO of Abivax, explains why drug-candidate ABX464 has the potential to address the urgent need for new, safe short- and long-term effective drugs to treat Inflammatory Bowel Diseases.

The impact and importance of psychedelic medicine

Here, we discover the impact and importance of psychedelic medicine through the eyes of Amanda Feilding, Director of The Beckley Foundation.

COVID-19 vaccines: Risks versus benefits

Lauren Matelski, Jeremy MacMahon, and Pamela J. Lein from the University of California, Davis, weigh the risks associated with COVID-19 vaccines versus the benefits.

Glycoscience offers opportunities galore in healthcare

Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explains how glycoscience offers opportunities galore in healthcare.

Malaria deaths reduced by 70% with vaccine and drug combination

A combination of the world’s first malaria vaccine RTS,S/AS01E and antimalarial drugs reduce child hospitalisations and death by 70%.

Five new research projects will examine COVID-19 vaccine responses

Five new COVID-19 research projects will study the durability of vaccine responses, low responses linked with health conditions and the effect of booster shots.

UK orders 35 million more Pfizer/BioNTech vaccine doses

The UK Government has signed a contract for 35 million more doses of the Pfizer/BioNTech COVID-19 vaccine, to be delivered from the second half of 2022..

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders